The findings — published today in Nature — provide
significant insights into cell
types fated to relapse and can help accelerate the quest for new, upfront therapies, says Dr. Dick, a Senior Scientist at Princess Margaret Cancer Centre, University Health Network, and Professor in the Department
of Molecular Genetics, University
of Toronto.